Skip to main content
Clinical Trials/NCT02010619
NCT02010619CompletedNot Applicable

Internet Delivered Cognitive Behavior Therapy for Body Dysmorphic Disorder - a Randomized Controlled Trial

Karolinska Institutet2 sites in 1 country94 target enrollmentStarted: November 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
94
Locations
2
Primary Endpoint
Body Dysmorphic Disorder Modification of the Y-BOCS (BDD-YBOCS)

Study Overview

Brief Summary

To evaluate if Internet delivered cognitive behavior therapy is an efficacious treatment when compared to a control group consisting of supportive therapy.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • outpatient
  • ≥ 18 years
  • primary diagnosis of BDD according to the DSM-5
  • BDD-YBOCS ≥20
  • regular access to a computer with Internet access and skills to use the web.

Exclusion Criteria

  • psychotropic medication changes within two months prior to the treatment,
  • completed CBT for BDD within the last 12 months,
  • other primary axis I diagnosis
  • current substance dependence
  • lifetime bipolar disorder or psychosis
  • suicidal ideation
  • Axis II diagnosis that could jeopardize treatment participation,
  • other current psychological treatment that could affect BDD symptoms
  • A serious medical illness that precludes participation in the study

Arms & Interventions

Cognitive behavior therapy

Experimental

Intervention: Cognitive behavior therapy (Behavioral)

Supportive therapy

Active Comparator

Intervention: Supportive therapy (Behavioral)

Outcomes

Primary Outcomes

Body Dysmorphic Disorder Modification of the Y-BOCS (BDD-YBOCS)

Time Frame: Change in BDD-YBOCS from baseline (week 0) to post-treatment (week 12)

Secondary Outcomes

  • The Montgomery Åsberg Depression Rating Scale - self report (MADRS-S)(Change in MADRS-S from baseline (week 0) to post-treatment (week 12))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Christian Rück

Associate professor, M.D.

Karolinska Institutet

Study Sites (2)

Loading locations...

Similar Trials